Patients Views & Analysis

Views & Analysis

Patients

new-drug discovery, development, and delivery

From patient engagement to patient centricity

Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon.

Oncology

Regulation optimisation could save thousands of life years

Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across the European Union.

Patients

How the combination treatment challenge impacts patients and...

How the combination treatment challenge impacts patients

Deep Dive

Recruiting patients to increase diversity & inclusion in cli...

More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community.

Patients

How biomarkers and bioanalytics are changing R&D

Biomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they are bringing the pharma industry a new gold standard for clinical research.

Patients